Pomegranate extract inhibited proliferation of endothelial (HUVEC) and prostate (LNCaP) cancer cells; the extract also reduced LNCaP prostate cancer xenograft size, tumor vessel density, VEGF peptide levels and HIF-α expression after four weeks of treatment in severe combined immunodeficient mice [65]. Here, VEGFA is linked to neoplasm.